Chen Pei-jer
#120,932
Most Influential Person Now
Taiwanese hepatologist
Chen Pei-jer's AcademicInfluence.com Rankings
Chen Pei-jerphilosophy Degrees
Philosophy
#6082
World Rank
#9053
Historical Rank
Logic
#3275
World Rank
#4406
Historical Rank
Download Badge
Philosophy
Chen Pei-jer's Degrees
- Doctorate Medicine National Taiwan University
- PhD Medical Science National Taiwan University
Why Is Chen Pei-jer Influential?
(Suggest an Edit or Addition)According to Wikipedia, Chen Pei-jer is a Taiwanese hepatologist and an academician of Academia Sinica. Early life and education Chen Pei-jer was raised by his grandparents in Shalu, Taichung, while his parents worked in northern Taiwan. He and his three siblings had a strict routine, awakening at 6:00 am daily to exercise and do chores alongside their grandfather, followed by Chinese calligraphy practice. Chen earned a medical degree from National Taiwan University in 1981, and he completed a doctorate at University of Pennsylvania Medical School in 1987.
Chen Pei-jer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update (2017) (1338)
- Hepatitis B e antigen and the risk of hepatocellular carcinoma. (2002) (1243)
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma (2010) (1013)
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study (2015) (706)
- Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma (2008) (566)
- Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. (2005) (563)
- Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. (2003) (529)
- Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. (2008) (514)
- Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. (2011) (508)
- Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial. (2015) (478)
- High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. (2012) (464)
- How common is non‐alcoholic fatty liver disease in the Asia–Pacific region and are there local differences? (2007) (404)
- Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. (2003) (395)
- The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo (2014) (345)
- A revisit of prophylactic lamivudine for chemotherapy‐associated hepatitis B reactivation in non‐Hodgkin's lymphoma: A randomized trial (2008) (306)
- Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells (2011) (285)
- Steroid‐free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV‐carriers with lymphoma (2003) (278)
- High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. (2006) (271)
- MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. (2009) (257)
- An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection (2006) (252)
- Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. (2012) (251)
- Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. (2010) (248)
- Chemotherapy‐induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study (2014) (242)
- Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads (2013) (230)
- Detection of SARS-associated Coronavirus in Throat Wash and Saliva in Early Diagnosis (2004) (222)
- Treatment of Liver Cancer. (2015) (218)
- Epidemiologic Features of Kawasaki Disease in Taiwan, 2003–2006 (2009) (215)
- Gender Disparity of Hepatocellular Carcinoma: The Roles of Sex Hormones (2010) (213)
- Genotypes and Clinical Phenotypes of Hepatitis B Virus in Patients with Chronic Hepatitis B Virus Infection (2002) (212)
- Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. (2004) (211)
- Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. (2009) (211)
- Percutaneous Ethanol Injection Versus Surgical Resection for the Treatment of Small Hepatocellular Carcinoma: A Prospective Study (2005) (203)
- Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters. (2011) (197)
- Dissemination, divergence and establishment of H7N9 influenza viruses in China (2015) (196)
- Epidemiologic Features of Kawasaki Disease in Taiwan, 1996–2002 (2004) (196)
- Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial. (2008) (194)
- Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. (2006) (178)
- Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. (2013) (174)
- Occult Hepatitis B Virus Infection and Clinical Outcomes of Patients with Chronic Hepatitis C (2002) (171)
- Generation and Characterization of DNA Vaccines Targeting the Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus (2004) (168)
- Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B– and C–related risk (2003) (167)
- Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers (2004) (165)
- Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects (2020) (162)
- Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors. (2012) (161)
- Sorafenib Overcomes TRAIL Resistance of Hepatocellular Carcinoma Cells through the Inhibition of STAT3 (2010) (159)
- Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota (2015) (156)
- Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma (2013) (156)
- Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. (2008) (154)
- Identification of androgen response elements in the enhancer I of hepatitis B virus: A mechanism for sex disparity in chronic hepatitis B (2009) (153)
- Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study. (2010) (151)
- Molecular and Phylogenetic Analyses Suggest an Additional Hepatitis B Virus Genotype “I” (2010) (150)
- Glycogen Synthase Kinase-3 Regulates the Phosphorylation of Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein and Viral Replication* (2009) (150)
- Nucleocapsid Phosphorylation and RNA Helicase DDX1 Recruitment Enables Coronavirus Transition from Discontinuous to Continuous Transcription (2014) (148)
- Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma. (2011) (147)
- Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma. (2004) (147)
- p53 gene and Wnt signaling in benign neoplasms: β‐catenin mutations in hepatic adenoma but not in focal nodular hyperplasia (2002) (147)
- Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage. (2009) (139)
- Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data (2011) (137)
- Determinants of spontaneous surface antigen loss in hepatitis B e antigen–negative patients with a low viral load (2012) (135)
- Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level (2007) (135)
- Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study. (2006) (133)
- PD-1 Blockage Reverses Immune Dysfunction and Hepatitis B Viral Persistence in a Mouse Animal Model (2012) (133)
- Cellular Immune Response to HBcAg in Mother‐to‐Infant Transmission of Hepatitis B Virus (1992) (131)
- Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients (2003) (131)
- Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. (2004) (129)
- Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. (2006) (122)
- Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma. (2010) (120)
- Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy. (2014) (117)
- Hepatitis B viral factors in HBeAg‐Negative carriers with persistently normal serum alanine aminotransferase levels (2007) (116)
- High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C (2007) (115)
- Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. (2006) (113)
- Dovitinib Induces Apoptosis and Overcomes Sorafenib Resistance in Hepatocellular Carcinoma through SHP-1–Mediated Inhibition of STAT3 (2011) (112)
- Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. (2005) (112)
- Viral hepatocarcinogenesis: from infection to cancer (2008) (111)
- RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant (2005) (110)
- Effect of Parenteral Selenium Supplementation in Critically Ill Patients: A Systematic Review and Meta-Analysis (2013) (109)
- Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. (2003) (107)
- Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen (2015) (102)
- Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection (2012) (101)
- Estrogen receptor α represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4α. (2012) (99)
- Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers (2014) (98)
- Pegylated Interferon-α2a With or Without Low-Dose Ribavirin for Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Receiving Hemodialysis (2013) (97)
- Radiation-Induced Hepatitis B Virus Reactivation in Liver Mediated by the Bystander Effect from Irradiated Endothelial Cells (2007) (96)
- Bortezomib Overcomes Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance in Hepatocellular Carcinoma Cells in Part through the Inhibition of the Phosphatidylinositol 3-Kinase/Akt Pathway* (2009) (95)
- Clinical and Virological Aspects of Blood Donors Infected with Hepatitis B Virus Genotypes B and C (2002) (95)
- Phase 2 trial of linifanib (ABT‐869) in patients with unresectable or metastatic hepatocellular carcinoma (2013) (94)
- Androgen pathway stimulates MicroRNA‐216a transcription to suppress the tumor suppressor in lung cancer‐1 gene in early hepatocarcinogenesis (2012) (93)
- Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV. (2017) (92)
- Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c‐Src and glycogen synthase kinase‐3β kinase pathways (2009) (92)
- Role of microRNAs in hepatitis B virus replication and pathogenesis. (2011) (91)
- Acute exacerbations of chronic hepatitis B are rarely associated with superinfection of hepatitis B virus (2001) (90)
- Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. (2007) (88)
- Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B (2010) (88)
- OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci (2006) (88)
- Association of pre‐S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma (2007) (86)
- Transfusion‐transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers (2002) (86)
- Effect of Host and Viral Factors on Hepatitis B E Antigen-Positive Chronic Hepatitis B Patients Receiving Pegylated Interferon-α-2A Therapy (2011) (85)
- Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects. (2010) (85)
- Intratypic Recombination among Lineages of Type 1 Vaccine-Derived Poliovirus Emerging during Chronic Infection of an Immunodeficient Patient (2005) (85)
- GBV-C in the aetiology of fulminant hepatitis (1996) (84)
- Lack of Association between Infection with a Novel Human Coronavirus (HCoV), HCoV-NH, and Kawasaki Disease in Taiwan (2006) (83)
- Distinct Hepatitis B Virus Dynamics in the Immunotolerant and Early Immunoclearance Phases (2010) (82)
- Phase III trial of linifanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC). (2013) (82)
- Gender disparity in chronic hepatitis B: Mechanisms of sex hormones (2015) (81)
- Phase I Dose-Finding Study of Pazopanib in Hepatocellular Carcinoma: Evaluation of Early Efficacy, Pharmacokinetics, and Pharmacodynamics (2011) (80)
- Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B). (2016) (80)
- Microbiologic Characteristics, Serologic Responses, and Clinical Manifestations in Severe Acute Respiratory Syndrome, Taiwan (2003) (79)
- No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization. (2010) (79)
- Basal core‐promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen‐negative chronic hepatitis B (2005) (78)
- Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. (2005) (77)
- Hepatitis B virus integration in hepatitis B virus‐related hepatocellular carcinoma in childhood (1991) (76)
- Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. (2007) (76)
- High Level of Hepatitis B Core-related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load. (2019) (76)
- Reduction of HBV replication prolongs the early immunological response to IFNα therapy. (2014) (76)
- Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor. (2005) (74)
- Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients. (2011) (74)
- Changes of serum hepatitis B virus DNA and aminotransferase levels during the course of chronic hepatitis B virus infection in children (1990) (73)
- A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation. (2003) (73)
- Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation. (2010) (71)
- Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan. (2015) (70)
- Re‐evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel (2014) (70)
- The origin and underlying driving forces of the SARS-CoV-2 outbreak (2020) (70)
- Laboratory-Based Surveillance and Molecular Epidemiology of Influenza Virus in Taiwan (2005) (70)
- Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion. (2007) (70)
- Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity. (2012) (70)
- Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA (2004) (69)
- Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis. (2006) (69)
- Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development. (2019) (69)
- Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy (2011) (68)
- Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model (2010) (68)
- Re-evaluation of the Carcinogenic Significance of Hepatitis B Virus Integration in Hepatocarcinogenesis (2012) (68)
- Patient data, early SARS epidemic, Taiwan. (2004) (67)
- Postpartum subsidence of hepatitis B viral replication in hbeag‐positive carrier mothers (1989) (67)
- Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin. (2004) (67)
- Low incidence of hepatitis C virus transmission between spouses: A prospective study (2000) (67)
- Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow‐up (2013) (66)
- Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study (2002) (66)
- The circulation of subgenogroups B5 and C5 of enterovirus 71 in Taiwan from 2006 to 2007. (2008) (66)
- Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients (2012) (66)
- A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus (2008) (66)
- The small delta antigen of hepatitis delta virus is an acetylated protein and acetylation of lysine 72 may influence its cellular localization and viral RNA synthesis. (2004) (65)
- Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C (2013) (64)
- Discovery of novel src homology region 2 domain‐containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma (2014) (62)
- Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection. (2018) (62)
- A research agenda for curing chronic hepatitis B virus infection (2018) (61)
- Identification and characterization of intrahepatic hepatitis b virus dna in hbsag‐seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan (1990) (61)
- Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition (2015) (60)
- Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping (2015) (60)
- Vaccination with a DNA vaccine encoding herpes simplex virus type 1 VP22 linked to antigen generates long-term antigen-specific CD8-positive memory T cells and protective immunity. (2004) (60)
- Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma. (2006) (59)
- Circulating Programmed Death-1 as a Marker for Sustained High Hepatitis B Viral Load and Risk of Hepatocellular Carcinoma (2014) (59)
- Infection Control and SARS Transmission among Healthcare Workers, Taiwan (2004) (59)
- Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC) (2013) (58)
- Natural course and treatment of dual hepatitis B virus and hepatitis C virus infections. (2005) (57)
- Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells. (2012) (56)
- Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters. (2012) (56)
- Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification (2013) (55)
- Influences of tobacco and alcohol use on hepatocellular carcinoma survival (2012) (55)
- Prevalence and implication of a newly identified infectious agent (SEN virus) in Taiwan. (2002) (55)
- Doxorubicin activates hepatitis B virus (HBV) replication in HBV-harboring hepatoblastoma cells. A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy. (2004) (54)
- Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma. (2004) (53)
- Natural course and treatment of hepatitis D virus infection. (2006) (53)
- Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality (2013) (53)
- Genotypic dominance and novel recombinations in HBV genotype B and C co‐infected intravenous drug users (2004) (53)
- Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions (2010) (53)
- Tumor Necrosis Factor-Alpha Induced by Hepatitis B Virus Core Mediating the Immune Response for Hepatitis B Viral Clearance in Mice Model (2014) (53)
- Structure-based discovery of triphenylmethane derivatives as inhibitors of hepatitis C virus helicase. (2009) (53)
- High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users (2004) (53)
- Rapid fluorescent lateral-flow immunoassay for hepatitis B virus genotyping. (2015) (52)
- Distinct Relapse Rates and Risk Predictors After Discontinuing Tenofovir and Entecavir Therapy (2018) (52)
- The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice (2005) (52)
- Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence. (2014) (52)
- DNA detection using commercial mobile phones. (2011) (51)
- Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full‐length viral sequences (2001) (51)
- A miniaturized quantitative polymerase chain reaction system for DNA amplification and detection (2009) (50)
- Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: Correlation with viral serotypes and clinical stages of liver disease (2002) (49)
- Application of hepatitis B virus genotyping and phylogenetic analysis in intrafamilial transmission of hepatitis B virus. (2005) (49)
- Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon‐induced hepatitis B e antigen seroconversion (2013) (49)
- Characterization of the spectrum of postthymic T‐cell malignancies in Taiwan a clinicopathologic study of HTLV‐1‐positive and HTLV‐1‐negative cases (1988) (49)
- Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management (2013) (49)
- Dual chronic hepatitis B virus and hepatitis C virus infection (2009) (49)
- Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation. (2012) (49)
- Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers. (2013) (48)
- Reduced Toll-Like Receptor 3 Expression in Chronic Hepatitis B Patients and Its Restoration by Interferon Therapy (2013) (48)
- Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A. (2004) (48)
- Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis (2004) (47)
- 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations. (2020) (47)
- Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing (2020) (47)
- Rapid DNA amplification in a capillary tube by natural convection with a single isothermal heater. (2011) (47)
- Sequence analysis of pre‐S/surface and pre‐core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection (2002) (46)
- Clustering of minimal deleted regions reveals distinct genetic pathways of human hepatocellular carcinoma. (2004) (46)
- Prevalence and implication of TT virus infection: Minimal role in patients with non‐A–E hepatitis in Taiwan (1999) (45)
- Interleukin 28B Genetic Polymorphisms and Viral Factors Help Identify HCV Genotype-1 Patients who Benefit from 24-Week Pegylated Interferon plus Ribavirin Therapy (2012) (44)
- Characterization of the Phosphorylated Forms and the Phosphorylated Residues of Hepatitis Delta Virus Delta Antigens (1999) (44)
- Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy (2009) (44)
- Management of hepatitis C virus infection in the Asia-Pacific region: an update. (2017) (44)
- 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population. (2020) (44)
- Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis B (2006) (43)
- Immunofluorescence Assay for Detection of the Nucleocapsid Antigen of the Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus in Cells Derived from Throat Wash Samples of Patients with SARS (2005) (43)
- δ Infection in asymptomatic carriers of hepatitis B surface antigen: Low prevalence of δ activity and effective suppression of hepatitis B virus replication (1988) (43)
- Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B (2002) (43)
- Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection (2017) (43)
- HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. (2010) (43)
- Chronic Hepatitis B Virus Infection: Disease Revisit and Management Recommendations. (2016) (42)
- The Double-stranded RNA-activated Kinase, PKR, Can Phosphorylate Hepatitis D Virus Small Delta Antigen at Functional Serine and Threonine Residues* (2002) (42)
- Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity. (2013) (42)
- The large form of hepatitis 6 antigen is crucial for assembly of hepatitis 6 virus (41)
- Association of Lipid Profiles With Hepatitis C Viral Load in Chronic Hepatitis C Patients With Genotype 1 or 2 Infection (2009) (41)
- Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial (2014) (41)
- Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3. (2012) (41)
- Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4‐year experience (2001) (40)
- TT virus infection in patients with chronic hepatitis B or C: Influence on clinical, histological and virological features (2000) (40)
- Development of risk scoring system for stratifying population for hepatocellular carcinoma screening (2015) (40)
- The Conserved Serine 177 in the Delta Antigen of Hepatitis Delta Virus Is One Putative Phosphorylation Site and Is Required for Efficient Viral RNA Replication (2001) (39)
- Issues and controversies of hepatocellular carcinoma‐targeted therapy clinical trials in Asia: experts' opinion (2010) (39)
- Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients (2017) (39)
- Metabolic profiles in patients with chronic hepatitis C: a case–control study (2008) (39)
- Taiwan consensus statement on the management of chronic hepatitis B. (2019) (39)
- Chromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization (2002) (39)
- Characterization of trans‐ and cis‐cleavage activity of the SARS coronavirus 3CLpro protease: basis for the in vitro screening of anti‐SARS drugs (2004) (38)
- Influence of Metabolic Syndrome, Viral Genotype and Antiviral Therapy on Superimposed Fatty Liver Disease in Chronic Hepatitis C (2005) (38)
- Hepatitis B Virus in the Colostra of HBeAg‐Positive Carrier Mothers (1993) (38)
- Hepatitis C viral infection increases the risk of lymphoid‐neoplasms: A population‐based cohort study (2016) (38)
- Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection (2010) (38)
- Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C. (2010) (38)
- Fine mapping of hepatitis B virus pre‐S deletion and its association with hepatocellular carcinoma (2012) (38)
- Elevated p53 promotes the processing of miR‐18a to decrease estrogen receptor‐α in female hepatocellular carcinoma (2015) (38)
- Hepatitis D Virus Genotypes in Intravenous Drug Users in Taiwan: Decreasing Prevalence and Lack of Correlation with Hepatitis B Virus Genotypes (2002) (38)
- Interferon‐α treatment in children and young adults with chronic hepatitis B: a long‐term follow‐up study in Taiwan (2008) (38)
- Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma (2017) (38)
- Bortezomib Sensitizes HCC Cells to CS-1008, an Antihuman Death Receptor 5 Antibody, through the Inhibition of CIP2A (2011) (38)
- The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network (2016) (37)
- A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma (2016) (37)
- Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region (2019) (37)
- Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct acting antivirals. (2019) (36)
- Genetic predisposition of responsiveness to therapy for chronic hepatitis C. (2006) (36)
- Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) (2020) (36)
- Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN‐α therapy (2005) (36)
- High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection (2009) (36)
- Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan. (2002) (36)
- SARS Exposure and Emergency Department Workers (2004) (36)
- Evolution of Hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C. (2006) (36)
- Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q12.11 (2005) (35)
- Esophageal varices: noninvasive diagnosis with duplex Doppler US in patients with compensated cirrhosis. (2008) (35)
- The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C. (2010) (35)
- Cost‐effectiveness of peginterferon alfa‐2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan (2007) (34)
- IL10 and IL10 Receptor Gene Variation and Outcomes After Unrelated and Related Hematopoietic Cell Transplantation (2009) (34)
- Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol (2013) (34)
- Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index. (2007) (34)
- Sexual transmission of HCV (1993) (33)
- Combining antiangiogenic therapy with immunotherapy exerts better therapeutical effects on large tumors in a woodchuck hepatoma model (2010) (33)
- Phosphorylation of Serine 177 of the Small Hepatitis Delta Antigen Regulates Viral Antigenomic RNA Replication by Interacting with the Processive RNA Polymerase II (2009) (33)
- Depletion of β-catenin from mature hepatocytes of mice promotes expansion of hepatic progenitor cells and tumor development (2011) (32)
- The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA. (2017) (32)
- Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection. (2020) (32)
- Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection (2018) (32)
- Long-Term Culture of Hepatocytes from Human Adults (1998) (32)
- Report from a Viral Hepatitis Policy Forum on implementing the WHO Framework for Global Action on viral hepatitis in North Asia. (2013) (31)
- High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users (2007) (31)
- Interspousal transmission of GB virus‐C/hepatitis G virus: A comparison with hepatitis C virus (1997) (31)
- Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications (2014) (31)
- The evolution of real-time PCR machines to real-time PCR chips. (2010) (31)
- Simultaneous genotyping of single nucleotide polymorphisms in the IL-1 gene complex by multiplex polymerase chain reaction-restriction fragment length polymorphism. (2002) (31)
- Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C (2009) (31)
- Quasispecies of Hepatitis C Virus and Genetic Drift of the Hypervariable Region in Chronic Type C Hepatitis (1995) (31)
- Nucleolar Targeting of Hepatitis Delta Antigen Abolishes Its Ability To Initiate Viral Antigenomic RNA Replication (2007) (31)
- New Variants and Age Shift to High Fatality Groups Contribute to Severe Successive Waves in the 2009 Influenza Pandemic in Taiwan (2011) (31)
- Metabolic risk factors are associated with non‐hepatitis B non‐hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B (2018) (30)
- Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B. (2009) (30)
- A phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2, and VEGFR in advanced hepatocellular carcinoma (HCC). (2012) (30)
- Isolation of a complementary DNA fragment of hepatitis C virus in Taiwan revealed significant sequence variations compared with other isolates (1991) (30)
- New Insights into the Evolutionary Rate of Hepatitis B Virus at Different Biological Scales (2015) (30)
- Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice (2016) (29)
- Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model (2015) (29)
- Genetic and Epidemiological Analysis of Influenza Virus Epidemics in Taiwan during 2003 to 2006 (2008) (29)
- Concurrent delivery of GM‐CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors (2003) (29)
- Mechanism of vertical transmission of hepatitis G (1996) (29)
- A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice (2019) (28)
- Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf. (2011) (28)
- Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models (2007) (28)
- SEN virus infection in patients with chronic hepatitis C: preferential coinfection with hepatitis C genotype 2a and no effect on response to therapy with interferon plus ribavirin. (2003) (28)
- Chronic hepatitis B is associated with an increased risk of B‐cell non‐Hodgkin's lymphoma and multiple myeloma (2019) (28)
- Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant. (2013) (27)
- Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women (2002) (27)
- HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis. (2020) (27)
- Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients With Chronic Hepatitis C Virus Infection (2018) (27)
- Status of hepatitis B virus DNA in hepatocellular carcinoma: A study based on paired tumor and nontumor liver tissues (1988) (27)
- Real‐world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan (2018) (27)
- Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease (2021) (26)
- A micro circulating PCR chip using a suction-type membrane for fluidic transport (2009) (26)
- Seroprevalence of Hepatitis E Virus Infection among Swine Farmers and the General Population in Rural Taiwan (2013) (26)
- Interleukin 28B Genetic Polymorphisms Play a Minor Role in Identifying Optimal Treatment Duration in HCV Genotype 1 Slow Responders to Pegylated Interferon plus Ribavirin (2012) (25)
- Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis‐C virus infection in Taiwan: a prospective study (2003) (25)
- Original ArticlesGenetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study☆ (2002) (25)
- Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan (2005) (25)
- Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study (2018) (25)
- Low prevalence of hepatitis C virus and infrequent perinatal or spouse infections in pregnant women in Taiwan (1991) (25)
- Lymphocyte Antigen 6 Complex, Locus C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in Mice (2019) (24)
- Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16INK4A, and p19ARF genes in nasopharyngeal carcinoma (2002) (24)
- The role of phylogenetic analysis in clarifying the infection source of a COVID-19 patient (2020) (24)
- Synergistic effect of radiation and interleukin-6 on hepatitis B virus reactivation in liver through STAT3 signaling pathway. (2009) (24)
- Hepatitis C Viral Infection in Thalassemic Children: Clinical and Molecular Studies (1996) (24)
- Hepatitis B viraemia: its heritability and association with common genetic variation in the interferon γ signalling pathway (2010) (24)
- Plasma Adipokines and Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus–Infected Carriers: A Prospective Study in Taiwan (2014) (24)
- Dominance of functional androgen receptor allele with longer CAG repeat in hepatitis B virus-related female hepatocarcinogenesis. (2002) (24)
- The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism. (2008) (23)
- Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop (2017) (23)
- Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion (2004) (23)
- ERK1/2-Mediated Phosphorylation of Small Hepatitis Delta Antigen at Serine 177 Enhances Hepatitis Delta Virus Antigenomic RNA Replication (2008) (23)
- ADAR2-Mediated Editing of miR-214 and miR-122 Precursor and Antisense RNA Transcripts in Liver Cancers (2013) (23)
- Characterization of integration patterns and flanking cellular sequences of hepatitis B virus in childhood hepatocellular carcinomas (2002) (23)
- Telomerase‐specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice (2013) (23)
- Cell‐Free Virus‐Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer (2020) (23)
- A Lego®-like swappable fluidic module for bio-chem applications (2014) (23)
- Targeting histone deacetylase 4/ubiquitin‐conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice (2018) (23)
- Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma (2007) (22)
- Liver Sinusoidal Endothelial Cell Lectin Inhibits CTL-Dependent Virus Clearance in Mouse Models of Viral Hepatitis (2013) (22)
- Genetic analysis and evaluation of the reassortment of influenza B viruses isolated in Taiwan during the 2004-2005 and 2006-2007 epidemics. (2008) (22)
- Ribavirin Enhances Interferon-γ Levels in Patients with Chronic Hepatitis C Treated with Interferon-α (2001) (22)
- Reduced Toll-Like Receptor 9 Expression on Peripheral C D14+ Monocytes of Chronic Hepatitis B Patients and its Restoration by Effective Therapy (2014) (22)
- Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen‐Seronegative Patients (2019) (22)
- Simultaneous genotyping of single nucleotide polymorphisms in the IL-6, IL-10, TNFα and TNFβ genes (2002) (22)
- Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B (2012) (22)
- Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection. (2014) (22)
- D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage (2021) (22)
- A Procalcitonin-Based Algorithm to Guide Antibiotic Therapy in Secondary Peritonitis following Emergency Surgery: A Prospective Study with Propensity Score Matching Analysis (2014) (21)
- Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study (2009) (21)
- Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists. (2012) (21)
- Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients (2016) (21)
- Epigenetic activation of α4, β2 and β6 integrins involved in cell migration in trichostatin A-treated Hep3B cells (2005) (21)
- Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection (2013) (21)
- Linifanib phase II trial in patients with advanced hepatocellular carcinoma (HCC). (2010) (20)
- Hepatitis C virus infection in Taiwan (1991) (20)
- Allelic loss of chromosome 4q21 ≈︁ 23 associates with hepatitis B Virus—related hepatocarcinogenesis and elevated alpha‐fetoprotein (2004) (20)
- Early Viral Kinetics during Treatment of Chronic Hepatitis C Virus Infection with Pegylated Interferon Alpha plus Ribavirin in Taiwan (2007) (20)
- Allelic loss of chromosome 4q21 approximately 23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein. (2004) (20)
- Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC bridge study: First characterization of the full study population. (2012) (20)
- Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection (2016) (19)
- Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients (2005) (19)
- Long-Term Effect of Interferon Plus Ribavirin on Hepatitis B Surface Antigen Seroclearance in Patients Dually Infected with Hepatitis B and C Viruses (2011) (19)
- Sorafenib Action in Hepatitis B Virus X-Activated Oncogenic Androgen Pathway in Liver through SHP-1. (2015) (19)
- Origin of serum hepatitis B virus in acute exacerbation: Comparison with HBV in the liver and from other exacerbation (2004) (19)
- Dynamics of plasma hepatitis B virus levels after highly active antiretroviral therapy in patients with HIV infection. (2003) (19)
- Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment (2020) (19)
- Long-term culture of hepatocytes from human adults. (1998) (19)
- Comparison of two methods for quantification of hepatitis B viral DNA (1999) (18)
- Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients. (2005) (18)
- Genome‐wide association analysis identifies a GLUL haplotype for familial hepatitis B virus‐related hepatocellular carcinoma (2017) (18)
- Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase (2019) (18)
- Trichuris suis therapy for ulcerative colitis: nonresponsive patients may need anti-helminth therapy. (2005) (18)
- A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine‐treated chronic hepatitis B patients (2008) (18)
- Higher cut‐off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B (2006) (17)
- Sorafenib and its derivative SC‐49 sensitize hepatocellular carcinoma cells to CS‐1008, a humanized anti‐TNFRSF10B (DR5) antibody (2013) (17)
- Epigenetic activation of alpha4, beta2 and beta6 integrins involved in cell migration in trichostatin A-treated Hep3B cells. (2005) (17)
- Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters (2014) (17)
- Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay (2005) (17)
- Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System. (2015) (17)
- Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data. (2020) (17)
- A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients (2018) (17)
- Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy (2014) (17)
- Sofosbuvir‐based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection (2019) (17)
- Hepatitis B Virus Nucleocapsid but Not Free Core Antigen Controls Viral Clearance in Mice (2012) (17)
- Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real‐world effectiveness and safety in Taiwan (2019) (17)
- Emerging hepatitis B virus infection in vaccinated populations: a rising concern? (2012) (16)
- Genome‐wide identification of blood DNA methylation patterns associated with early‐onset hepatocellular carcinoma development in hepatitis B carriers (2017) (16)
- Serotyping of hepatitis C virus in chronic type C hepatitis in Taiwan: Correlation with genotypes (1996) (16)
- Hepatitis G Virus Infection in Normal and Prospectively Followed Posttransfusion Children (1997) (16)
- Prescription Patterns of Sorafenib and Outcomes of Patients with Advanced Hepatocellular Carcinoma: A National Population Study. (2017) (16)
- A forgotten population with chronic hepatitis C infection: Subjects coinfected with hepatitis B virus (2004) (16)
- Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan (2007) (16)
- Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan (2011) (16)
- Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg‐positive chronic hepatitis B patients receiving lamivudine therapy (2004) (16)
- Elimination of Hepatitis B in Highly Endemic Settings: Lessons Learned in Taiwan and Challenges Ahead (2020) (15)
- Disease burden from foodborne illnesses in Taiwan, 2012-2015. (2020) (15)
- Serum hepatitis B core‐related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load (2021) (15)
- De novo assembly of highly polymorphic metagenomic data using in situ generated reference sequences and a novel BLAST-based assembly pipeline (2017) (15)
- Serum hepatitis B surface antigen levels help predict disease progression in patients with low HBV loads. (2012) (15)
- Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up. (2017) (15)
- Oncolytic virotherapy for advanced liver tumours (2008) (15)
- Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy (2020) (15)
- Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy. (2012) (14)
- Molecular biology of hepatitis D virus: Research and potential for application (1997) (14)
- Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection (2014) (14)
- Perspectives on dual hepatitis B and C infection in Taiwan. (2016) (14)
- The driving circuit of HBx and androgen receptor in HBV-related hepatocarcinogenesis (2014) (14)
- Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels (2009) (14)
- Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B (2020) (14)
- Association of Adjuvant Antiviral Therapy with Risk of Cancer Progression and Deaths in Patients with Hepatitis-B-Virus-Related Hepatocellular Carcinoma following Curative Treatment: A Nationwide Cohort Study (2014) (14)
- Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post‐treatment or spontaneously (2014) (13)
- Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma (2016) (13)
- HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice (2020) (13)
- Minimal role of GB virus‐C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan (1999) (13)
- Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection (2010) (13)
- Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein[S] (2017) (13)
- Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy. (2018) (12)
- Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan (2018) (12)
- Lack of Interferon Sensitivity-Determining Region in the Genome of Hepatitis B Virus Genotype Ba (2004) (12)
- Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma. (2011) (12)
- Genetic mutation in hepatic adenoma: seeing is believing. (2006) (12)
- End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B. (2004) (12)
- Long-term Effectiveness of Population-wide Multifaceted Interventions for Hepatocellular Carcinoma in Taiwan. (2021) (12)
- A highly specific ELISA for diagnosis of 2009 influenza A (H1N1) virus infections. (2012) (12)
- A real-time convective PCR machine in a capillary tube instrumented with a CCD-based fluorometer (2013) (12)
- Feedback regulation of IFN‐α/β signaling by Axl receptor tyrosine kinase modulates HBV immunity (2015) (12)
- Efficacy of consensus interferon in the treatment of chronic hepatitis C (2000) (12)
- Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study (2015) (12)
- GBV-C/HGV infection and aplastic anaemia (1996) (12)
- Blood-bank screening for hepatitis G (1997) (12)
- Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan. (2020) (11)
- Hepatocellular Carcinoma and Hepatitis C Virus (2016) (11)
- Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis (2017) (11)
- Further genetic diversification in multiple tumors and an evolutionary perspective on therapeutics (2015) (11)
- Comparison of Three Different Immunoassays and PCR for the Detection of Hepatitis C Virus Infection in Pregnant Women in Taiwan (1993) (11)
- Hepatitis B virus Quantification and Detection of YMDD Mutants in a Single Reaction by Real-Time PCR and Annealing Curve Analysis (2008) (11)
- Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy. (2007) (11)
- Value of interleukin‐28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin (2014) (10)
- Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance (2021) (10)
- Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: Pharmacokinetics, safety, and preliminary efficacy (2021) (10)
- Secular Trends and Geographic Maps of Hepatitis C Virus Infection among 4 Million Blood Donors in Taiwan from 1999 to 2017 (2020) (10)
- Profile and value of FIB‐4 in patients with dual chronic hepatitis C and B (2018) (10)
- Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma (2006) (10)
- Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis. (2021) (10)
- Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection. (2019) (10)
- Ectopic liver with hepatocellular carcinoma in the peritoneum. (2007) (10)
- Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses (2013) (10)
- Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection (2019) (10)
- Serum Mac-2-binding protein glycosylation isomer at virological remission predicts hepatocellular carcinoma and death in chronic hepatitis B related cirrhosis. (2019) (9)
- Il-21R Gene Polymorphisms and Serum Il-21 Levels Predict Virological Response to Interferon-Based Therapy in Asian Chronic Hepatitis C Patients (2013) (9)
- Polymorphisms in XRCC 1 and Glutathione S-Transferase Genes and Hepatitis B – Related Hepatocellular Carcinoma (2003) (9)
- Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma (2020) (9)
- Disease progression in a patient with nonalcoholic steatohepatitis. (2008) (9)
- High-Resolution Melting and Real-Time Pcr for Quantification and Detection of Drug-Resistant HBV Mutants in a Single Amplicon (2012) (9)
- BRIEF COMMUNICATION: Efficacy of ribavirin plus interferon α on viraemia of GB virus‐C/hepatitis G virus: Comparison with interferon α alone (1998) (9)
- Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg‐Positive Children With a Normal Alanine Aminotransferase Level (2019) (9)
- Asialo GM1-positive liver-resident CD8 T cells that express CD44 and LFA-1 are essential for immune clearance of hepatitis B virus (2020) (9)
- Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions. (2019) (8)
- Heterogeneity of hereditary persistence of alpha-fetoprotein. (2004) (8)
- Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection. (2019) (8)
- Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver (2020) (8)
- SC-60, a Dimer-Based Sorafenib Derivative, Shows a Better Anti–Hepatocellular Carcinoma Effect than Sorafenib in a Preclinical Hepatocellular Carcinoma Model (2013) (8)
- Phase II study of sorafenib plus tegafur/uracil (UFT) in patients with advanced hepatocellular carcinoma (HCC) (2008) (8)
- 665 A PHASE I/II STUDY OF FORETINIB, AN ORAL MULTIKINASE INHIBITOR TARGETING MET, RON, AXL, TIE-2 AND VEGFR IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC) (2011) (8)
- Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy. (2015) (8)
- Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial (2015) (8)
- Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non‐cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis (2019) (8)
- Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis (2020) (8)
- IL 10 AND IL 10 RECEPTOR GENE VARIATION AND OUTCOMES AFTER UNRELATED AND RELATED HEMATOPOIETIC CELL TRANSPLANTATION (2009) (8)
- Molecular cloning and expression of woodchuck granulocyte‐macrophage colony stimulating factor * (2001) (8)
- Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trial (2015) (8)
- SYNERGISM BETWEEN IL-10 GENOTYPE OF PATIENT AND IL-10 RECEPTOR-β GENOTYPE OF DONOR (2005) (7)
- Polymerase chain reaction with phase change as intrinsic thermal control (2013) (7)
- A prospect for pharmacogenomics in the interferon therapy of chronic viral hepatitis. (2003) (7)
- One step closer to an experimental infection system for Hepatitis B Virus? --- the identification of sodium taurocholate cotransporting peptide as a viral receptor (2013) (7)
- Anti-viral treatment and cancer control. (2014) (7)
- Final Results of Open-Label Treatment with Eltrombopag During ENABLE 1: A Study of Eltrombopag As An Adjunct for Antiviral Treatment of Hepatitis C Virus Associated with Thrombocytopenia (2011) (7)
- Long-term evolution of estimated glomerular filtration rate in patients with antiviral treatment for hepatitis C virus infection. (2022) (7)
- Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection (2015) (7)
- 6517 International phase 2 trial of ABT-869 in patients with advanced hepatocellular carcinoma (HCC) (2009) (6)
- Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials (2020) (6)
- Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C. (2016) (6)
- Human leukocyte antigen‐DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus (2009) (6)
- Hepatitis B viral genotype in Taiwanese patients with acute hepatitis B. (2008) (6)
- Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients (2013) (6)
- Dexamethasone ameliorates severe pneumonia but slightly enhances viral replication in the lungs of SARS-CoV-2-infected Syrian hamsters (2022) (6)
- Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents. (2021) (6)
- Transfusion-transmitted human T-cell lymphotropic virus type I infection in Taiwan: a true risk and occasional coinfection with hepatitis C virus shown in a prospective study (1994) (6)
- HCV Core Gene Polymorphisms Correlate with Liver Fibrosis but Not Sustained Virological Response in Patients with Genotype 1 Infection (2011) (6)
- Physician-scientist: attitude of graduates of clinical medicine graduate schools. (2008) (6)
- Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus–Associated Hepatocellular Carcinoma (2019) (6)
- High Risk of clinical relapse in HBV-infected patients after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy. (2020) (5)
- Robust induction of TRMs by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses (2021) (5)
- Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus‐coinfected patients receiving sofosbuvir‐based direct‐acting antivirals and antiretroviral therapy (2021) (5)
- Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response. (2017) (5)
- O115 PEGINTERFERON LAMBDA FOR THE TREATMENT OF CHRONIC HEPATITIS B (CHB): A PHASE 2B COMPARISON WITH PEGINTERFERON ALFA IN PATIENTS WITH HBeAg-POSITIVE DISEASE (2014) (5)
- Gut microbiota in the innate immunity against hepatitis B virus - implication in age-dependent HBV clearance. (2021) (5)
- A novel toolbox for the in vitro assay of hepatitis D virus infection (2017) (5)
- Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters (2021) (5)
- Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV (2021) (5)
- Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis (2022) (5)
- Specific diacylglycerols generated by hepatic lipogenesis stimulate the oncogenic androgen receptor activity in male hepatocytes (2019) (5)
- 1206 Phase I study of Pazopanib (PAZ) in Hepatocellular Carcinoma (HCC): evaluation of clinical activity, Pharmacokinetics (PK), and Dynamic Contrast Enhanced MRI (DCE-MRI) (2009) (5)
- Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan. (2017) (5)
- Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B‐related hepatocellular carcinoma (2020) (5)
- Eastern asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma (2010) (5)
- Ledipasvir/sofosbuvir for 12 weeks is safe and effective in patients with chronic hepatitis C and hepatitis B coinfection: A phase 3 study in Taiwan (2017) (4)
- Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer (2019) (4)
- Entecavir prevents HBV reactivation during direct acting antivirals for HCV/HBV dual infection: a randomized trial (2021) (4)
- Activation of PI3K/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells (2011) (4)
- Asian Pacific Association for Study of the Liver (APASL) (2003) (4)
- HBeAg(+) and sex ratio of offspring: Evidence form Taiwan's three million newborns (2012) (4)
- Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma (2021) (4)
- Hydrodynamic HBV Transfection Mouse Model. (2017) (4)
- Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy (2009) (4)
- PI-88, a novel heparanase inhibitor, as adjuvant therapy for hepatocellular carcinoma: A large randomized phase II clinical trial (2007) (4)
- Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase (2022) (4)
- 27 Risk of hepatocellular carcinoma associated with genotypes and mutants of hepatitis B virus: A community-based prospective cohort study (2006) (4)
- 758 ENTECAVIR PLUS PEGINTERFERON alfa-2a vs. ENTECAVIR ALONE IN THE TREATMENT OF HEPATITIS B e ANTIGEN-POSITIVE CHRONIC HEPATITIS B: AN INTERIM REPORT (2013) (4)
- Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model (2016) (4)
- Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studies (2016) (3)
- Cell-free junctional DNA fragment from hepatitis B virus integration in HCC for monitoring postresection recurrence and clonality. (2019) (3)
- The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice (2018) (3)
- Splicing Mutations of the p 53 Gene in Human Hepatocellular Carcinoma 1 (2006) (3)
- Genetic structural differences between responders and non-responders to interferon therapy for chronic hepatitis-B patients (2006) (3)
- 82 Sorafenib and Its Derivative SC-59 Induces Autophagy in Hepatocellular Carcinoma Through SHP-1 Dependent Inhibition of STAT3 (2012) (3)
- Androgen receptor functions in pericentral hepatocytes to decrease gluconeogenesis and avoid hyperglycemia and obesity in male mice. (2022) (3)
- Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment (2021) (3)
- [610] AN OPEN-LABEL, COMPARATIVE, MULTICENTER STUDY OF PEGINTERFERON a-2a PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C/HEPATITIS B CO-INFECTION VERSUS CHRONIC HEPATITIS C MONOINFECTION: AN INTERIM REPORT (2007) (3)
- Prospect of individualized medicine in chronic hepatitis C therapy by pharmacogenomics (2006) (3)
- A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C (2022) (3)
- Androgen Receptor Enhances Hepatic TERT Transcription after Hepatitis B Virus Integration or Point Mutation in Promoter Region. (2018) (3)
- IL-21 R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients (2013) (3)
- NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging (2019) (3)
- Acute-phase serum amyloid A for early detection of hepatocellular carcinoma in cirrhotic patients with low AFP level (2022) (3)
- Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan. (2020) (3)
- Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment (2021) (3)
- 739 ALT FLARES DURING TREATMENT WITH PEGINTERFERON LAMBDA OR PEGINTERFERON alfa IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B INFECTION (CHB) (2013) (2)
- Dexamethasone ameliorates severe pneumonia but slightly enhances viral replication in the lungs of SARS-CoV-2-infected Syrian hamsters (2022) (2)
- Serial Follow-up of Hepatitis C Virus RNA and Antibody in Infants Born to Hepatitis C Virus Positive but Human Immunodeficiency Virus Negative Mothers (1994) (2)
- Both hepatitis A and hepatitis D infections may be associated with more advanced liver disease in patients with chronic hepatitis B (2020) (2)
- Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study. (2015) (2)
- Investigating the prevalence and clinical effects of hepatitis delta viral infection in Taiwan. (2021) (2)
- The effect of interferon plus ribavirin or interferon alone on the development of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis C (2002) (2)
- Abstract A105: Phase 2 trials of linifanib (ABT‐869) in advanced hepatocellular, renal cell and non‐small cell lung cancer: Associations of response by CT or DCE‐MRI with patient outcome (2009) (2)
- HCC BRIDGE study : BRIDGE to better outcomes in hepatocellular carcinoma (2009) (2)
- Corrigendum to "Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity" [Eur. J. Med. Chem. 55 (2012) 220-227]. (2018) (2)
- Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma. (2022) (2)
- D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Viral Transmission via Enhanced Furin-mediated Spike Cleavage (2021) (2)
- AB032. S7-3. Introduction of Taiwan Liver Cancer Network (2019) (1)
- Nomograms for risk of heptocellular carcinoma in patients with chronic heaptitis B virus infection (2010) (1)
- P0648 : Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection (2015) (1)
- Tu1502 – Ledipasvir/Sofosbuvir is Highly Effective and Safe in Patients with Chronic Hepatitis B Virus and Hepatitis C Virus Coinfection: Final Study Results (2019) (1)
- STRUCTURAL-FUNCTIONAL ANALYSIS OF BIOPOLYMERS AND THEIR COMPLEXES Synthesis in Escherichia coli Cells and Characterization of the Active Exoribonuclease of Severe Acute Respiratory Syndrome Coronavirus 1 (2009) (1)
- Erratum to: Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma". (2017) (1)
- Abstract A155: Activation of PI3K/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells (2009) (1)
- Phase I Dose-Escalation Study for Tirapazamine ChemoEmbolization in Unresectable Early and Intermediate Stage Hepatocellular Carcinoma. (2022) (1)
- Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence. (2013) (1)
- CHAPTER 66 – Hepatitis B and Deltavirus Infections (2011) (1)
- 699 OBSERVED PATTERNS OF SYSTEMIC THERAPY USE IN HEPATOCELLULAR CARCINOMA (HCC) PATIENTS FROM THE MULTINATIONAL HCC BRIDGE STUDY: RESULTS OF A SECOND INTERIM ANALYSIS (2012) (1)
- Sexual transmission of HCV [letter] (1993) (1)
- Association of IL-10 and IL-10 Receptor Gene Polymorphisms and Graft-Versus-Host Disease Following Hematopoietic Cell Transplantation. (2004) (1)
- 527 SUSTAINED HCV CLEARANCE AND INCREASED HBSAG SEROCLEARANCE IN PATIENTS WITH DUAL CHRONIC HEPATITIS C AND B POST-PEGINTERFERON ALFA-2A AND RIBAVIRIN TREATMENT: A 5-YEAR FOLLOW-UP (2012) (1)
- 381 SERUM HEPATITIS B VIRUS DNA LEVEL AT ONE YEAR AFTER HEPATITIS B E ANTIGEN SEROCONVERSION PREDICTS SUBSEQUENT HEPATITIS B REACTIVATION (2009) (1)
- P174 THE CRISPR/Cas9 SYSTEM FACILITATES ELIMINATION OF THE PERSISTENT INTRAHEPATIC HBV GENOMES IN VIVO (2014) (1)
- THE VARIATION OF THE QUASISPECIES OF HEPATITIS C VIRUS IS HOMOGENIZED AND ACCELERATED BY BONE MARROW TRANSPLANTATION (1995) (1)
- Phosphatidylinositol 3-Kinase/Akt Pathway Cells in Part through the Inhibition of the Resistance in Hepatocellular Carcinoma Factor-related Apoptosis-inducing Ligand Bortezomib Overcomes Tumor Necrosis Mechanisms of Signal Transduction: (2014) (1)
- Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission (2012) (1)
- SAT-243-Ledipasvir/sofosbuvir is highly effective and safe in patients with chronic hepatitis B virus and hepatitis C virus coinfection: Final study results (2019) (1)
- Prognostic Ability Of Systemic Immune-Inflammation Index In Oral Cavity Patients After Curative Surgery And Post-Operative Radiotherapy. (2020) (1)
- Preclinical Development Bortezomib Sensitizes HCC Cells to CS-1008 , an Antihuman Death Receptor 5 Antibody , through the Inhibition of CIP 2 A (2011) (1)
- Peginterferon Lambda, a New Potential Therapeutic Option for the Treatment of Chronic Hepatitis B: A Phase 2B Comparison with Peginterferon Alfa in Patients with HBeAg-Positive Disease (2012) (1)
- Micro‐evolution of the hepatitis B virus genome in hepatitis B e‐antigen‐positive carriers: Comparison of genotypes B and C at various immune stages (2015) (1)
- Abstract 2780: Bortezomib induces autophagy in hepatocellular carcinoma through the inhibition of CIP2A independent of proteasome inhibition. (2012) (1)
- Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study (2022) (1)
- Hepatitis B Virus DNA Integration Drives Carcinogenesis and Provides a New Biomarker for HBV-related HCC (2023) (1)
- Development of Vaccines and Passive Immunotherapy Against Sars Coronavirus Using Mouse and Scid-PBL/hu Mouse Models (2006) (1)
- Contrasting Patterns in the Early Stage of SARS-CoV-2 Evolution between Humans and Minks (2022) (1)
- afenib Overcomes TRAIL Resistance of Hepatocellular R cinoma Cells through the Inhibition of STAT 3 (2010) (1)
- Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma". (2017) (1)
- Acute Upper Gastrointestinal Bleeding (UGIB) In A Resource Limited Setting Highly Endemic for Viral Hepatitis B: Which Etiologies for Which Real Clinical Practices? (2022) (1)
- 654 INTERFERON INHIBITS HBVRNA DETECTED DURING LAMIVUDINE THERAPY (2008) (1)
- Successful treatment with peginterferon and ribavirin in a patient with acute hepatitis C evolving into chronicity. (2005) (1)
- Circulating Virus–Host Chimera DNAs in the Clinical Monitoring of Virus-Related Cancers (2022) (1)
- P.043 An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection (2006) (1)
- Amebic Liver Abscess and Human Immunodeficiency Virus Infection (2001) (1)
- Abstract 2175: Src homology region 2 domain-containing phosphatase-1 is a major target of sorafenib in hepatocellular carcinoma. (2013) (0)
- Chapter XX Antiviral Treatment and Cancer Control. (2021) (0)
- Hepatitis B Virus: Pathogenesis and Host Immune Response (2014) (0)
- Baseline serum WFA+-M2BP level is a strong predictor of response to pegylated interferon-α in HBeAg-positive chronic hepatitis B patients (2017) (0)
- Androgen Enhances Aflatoxin-induced Genotoxicity and Inflammation to Liver Cancer in Male Hepatitis B Patients (2022) (0)
- The Impact of p53 Mutations on the Course of Hepatitis B or C-related Chronic Liver Diseases in Taiwan: 395 (2009) (0)
- Abstract 355: CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells (2010) (0)
- Long-Term Assessment of Renal Function in Patients following Antiviral Therapy for Chronic Hepatitis C Virus Infection (2016) (0)
- T1018 Negative Correlation Between Hepatitis B (HBV) and C (HCV) Viral Load in Co-Infected Persons (2008) (0)
- Abstract #4533: Bortezomib down-regulates phospho-Akt through up-regulation of protein phosphatase 2A activity in hepatocellular carcinoma cells (2009) (0)
- PL-005 Profile of HBsAg levels in patients with dual hepatitis B virus and hepatitis C virus infection treated with peginterferon alfa-2a and ribavirin (2009) (0)
- FRI-240-Comparison of Abbott RealTime HCV genotype II, Abbott HCV genotype plus RUO with Roche Cobas HCV genotyping assays for hepatitis C virus genotyping (2019) (0)
- CS1-04 Gender and HBV - Interaction between Human Sex Hormones and HBV Transcription/Replication (2009) (0)
- Prevalence and clinical implications of IL 28 B genotypes in Taiwanese patients with chronic hepatitis C (2016) (0)
- Abstract 4523: Design and synthesis of sorafenib analogues as SHP-1 activators for hepatocellular carcinoma cells (2011) (0)
- Predicting clinical outcome in a patient with chronic hepatitis B virus infection (2013) (0)
- Corrigendum to: “Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia” [J Hepatol 2013;59:1073–1080] (2014) (0)
- Identification of a Doubly-Spliced Viral Transcript in HBV-Infected Human Liver Tissues and Characterization of Translated Protein Products. (1989) (0)
- Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection. (2023) (0)
- Comparison of body weight and lipid profiles following tenofovir disoproxil fumarate or entecavir switching to tenofovir alafenamide-an interim analysis (2022) (0)
- Abstract 1915: Novel sorafenib derivatives (SC-40, SC-43 and SC-60) show better anti-tumor effects than sorafenib in hepatocellular carcinoma through SHP-1/STAT3-mediated signaling pathway (2012) (0)
- Front & Back Matter (2018) (0)
- Contents Vol. 7, 2018 (2018) (0)
- Optimizing survival benefit by surgical resection by the seven-eleven criteria in Barcelona clinic liver cancer stage A/B hepatocellular carcinoma beyond the Milan criteria (2023) (0)
- Exposure to Air Pollution and Survival in Follow-Up after Hepatocellular Carcinoma (2022) (0)
- Front & Back Matter (2018) (0)
- Front & Back Matter (2018) (0)
- De novo assembly of highly polymorphic metagenomic data using in situ generated reference sequences and a novel BLAST-based assembly pipeline (2017) (0)
- Front & Back Matter (2020) (0)
- Abstract 2743: Synergistic efficacy of telomerase-specific oncolytic adenoviral therapy and histone deacetylase inhibition in human hepatocellular carcinoma (2023) (0)
- 388 HEPATITIS B VIRUS X PROTEIN INDUCES TRANSCRIPTION OF HUMAN TNF-RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) GENE DEPENDS ON sp-1 (2013) (0)
- Title Chronic hepatitis B: Whom to treat and for how long? Propositions, challenges, and future directions (2010) (0)
- Gender Difference in Association between Metabolic Factors and Hepatocellular Carcinoma (2019) (0)
- Characterization ofRousSarcoma Virus-Related Sequences inthe Japanese Quail (1986) (0)
- Participation of 7S L RNA in Reverse Transcription by an Avian Retrovirus (1985) (0)
- MICRO Q-PCR CHIP ON A MINIATURIZED DETECTION SYSTEM FOR DNA DETECTION AND QUANTIFICATION (2008) (0)
- HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-related HCC with distinct features (2023) (0)
- High mortality rate in HBV-related cirrhosis patients with HEV superinfection (2018) (0)
- Bystander Synergy of Interleukin-6 for In Vivo Radiation-induced Hepatitis B Virus Reactivation in Liver Through STAT3 Pathway (2008) (0)
- Inhibition of Akt phosphorylation is involved in therapeutic synergy between telomerase-specific replication competent oncolytic adenovirus (Telomelysin) and histone deacetylase inhibitor (AR42) in human hepatocellular carcinoma (2017) (0)
- Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of HBsAg in Chronic Hepatitis B Patients with High HBsAg Levels. (2023) (0)
- Front & Back Matter (2020) (0)
- Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection (2023) (0)
- 687 SERUM IP-10 LEVEL ASSOCIATED WITH HEPATOCELLULAR CARCINOMA DEVELOPMENT IN PATIENTS WITH CHRONIC HEPATITIS B (2013) (0)
- Regulatory T cells alleviate allergic airway hyper‐responsiveness by modulating angiogenesis of airway remodelling via Notch signaling pathway (2008) (0)
- Estimated Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Rheumatic Diseases Treated with tumor Bnecrosis Factor Blockers (2012) (0)
- Establishment and Characterization of NS3 Protein-Specific T-Cell Clones from a Patient with Chronic Hepatitis C (1998) (0)
- The origin and underlying driving forces of the SARS-CoV-2 outbreak (2020) (0)
- Reply (2014) (0)
- P639 SPONTANEOUS SEROCLEARANCE OF HBsAg IN HEPATITIS B VIRUS/HEPATITIS C VIRUS DUALLY INFECTED PATIENTS: A 10-YEAR FOLLOW-UP (2014) (0)
- Breakthrough Hepatitis after Hepatitis Be Antigen Seroconversion during Extended Lamivudine Treatment: Report of a Case (2003) (0)
- Long-term Follow-up of Hepatitis B Surface Gene Mutant-Infected Children with (2013) (0)
- Lower Alanine Aminotransferase Level and Higher Hepatitis B Viral Load at Baseline Correlate with Earlier Emergence of Lamivudine Resistance in Taiwanese Patients: 314 (2009) (0)
- Abstract 2680A: Small molecule induces apoptosis through the inhibition of signal transducers and activators of transcription 3 in hepatocellular carcinoma cells (2010) (0)
- SAT-496-Circulating cell-free HBV-human chimera DNA as new marker for HCC recurrence and clonality after curative resection (2019) (0)
- Use of Tumor Necrosis Factor-α Antagonists in Patients with Concurrent Rheumatoid Arthritis or Spondyloarthritis and Hepatitis B (2011) (0)
- Every-two-week ropegienterferon alfa-2b is safe with higher hepatitis B e antigen seroconversion rate in interferon naive patients with chronic hepatitis B infection: A phase 2, open label, randomized, active control, dose finding study (2018) (0)
- Subject Index Vol. 78, Suppl. 1, 2010 (2010) (0)
- Organization of The Third International Symposium on Viral Hepatitis and Hepatocellular Carcinoma (1993) (0)
- In memoriam: Dr. Ding-Shinn Chen, 1943-2020. (2020) (0)
- HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice (2020) (0)
- Esophageal Varices: Noninvasive DiagnosiswithDuplexDopplerUSin PatientswithCompensatedCirrhosis 1 (2008) (0)
- Mouse Models of Viral Hepatitis Inhibits CTL-Dependent Virus Clearance in Liver Sinusoidal Endothelial Cell Lectin (2013) (0)
- Phosphorylation of Serine 177 of the Small Hepatitis Delta Antigen Regulates Viral Antigenomic RNA Replication by Interacting with the Processive RNA Polymerase II (2010) (0)
- Immunoglobulin M antibodies against hepatitis C virus antigens: significance and applications (1993) (0)
- Sa1531 PERSISTENT ON-TREATMENT ALANINE AMINOTRANSFERASE ELEVATION (POAE) IN PATIENTS WITH CHRONIC HEPATITIS C RECEIVING INTERFERON (IFN) FREE DIRECT ACTING ANTIVIRALS (DAAS) (2020) (0)
- Interferon-alpha/beta inhibit immunity towards HBV in a mouse model of HBV persistence (59.8) (2011) (0)
- Selenium for sepsis: what have we learned so far? (2013) (0)
- Abstract 4516: SC-2001, a SHP-1 enhancer, induces apoptosis in hepatocellular carcinoma through SHP-1 dependent STAT3 inactivation (2011) (0)
- 644 LIVER DISEASE PROGRESSION IN CHRONIC HEPATITIS B INFECTED PERSONS WITH NORMAL SERUM ALANINE AMINO TRANSFERASE LEVEL: UPDATE FROM THE R.E.V.E.A.L.-HBV STUDY (2008) (0)
- Signatures of adaptive evolution during human to mink SARS CoV2 cross-species transmission inform estimates of the COVID19 pandemic timing (2021) (0)
- Acute Fatty Liver of Pregnancy with Concurrent Acute Hepatitis B Virus Infection (2008) (0)
- OL-029 Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B (2009) (0)
- IDDF2022-ABS-0181 Combination of post-daa liver fibrosis and neutrophil-to-lymphocyte ratio predicts the development of liver-associated complications in chronic hepatitis C patients who achieve sustained virologic response (2022) (0)
- Mapping the conformational epitope of a therapeutic monoclonal antibody against HBsAg by in vivo selection of HBV escape variants (2021) (0)
- Virologic causes for DAA treatment failure of chronic hepatitis C (2020) (0)
- Suppressor and effector T cells exhibit differential migration capacity (2007) (0)
- Gene Expression and Interaction of HDV with HBV in an Hep G2 Cell Line Containing Integrated Cloned HDV DNA (1990) (0)
- Research Highlights: Pharmacogenomics of chronic hepatitis C (2009) (0)
- Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy. (2023) (0)
- 616 HEPATITIS B GENOMIC VARIABILITY CORRELATES WITH INTRAHEPATIC VIRAL ANTIGEN EXPRESSION (2010) (0)
- 378 Liver Disease Progression in Chronic Hepatitis B Infected Persons with Normal Serum Alanine Amino Transferase Level: Update from the R.E.V.E.A.L.-HBV Study (2008) (0)
- gutjnl-2014-308964supp (2015) (0)
- Sorafenib and SC-1 Exhibit Anti-fibrotic Effects Through Signal Transducer and Activator of Transcription 3 Inhibition (2015) (0)
- Long-term durability of sustained virologic response for hepatitis C virus infection in solid organ transplant recipients receiving direct-acting antivirals. (2023) (0)
- 117 SEROMARKERS FOR LONG-TERM PREDICTION OF HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH CHRONIC HEPATITIS C (2010) (0)
- HBsAg Profiles in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses (2010) (0)
- Exploring New Therapies for a Serological Cure of Chronic Hepatitis B (2018) (0)
- 16 ANALYSIS OF HBsAg LEVELS IN PATIENTS COINFECTED WITH HEPATITIS B VIRUS AND HEPATITIS C VIRUS TREATED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (2009) (0)
- Interferon and ribavirin combination therapy clears HCV in hepatitis B and C co-infection patients as effectively as in simple hepatitis C: a pilot study (2002) (0)
- High-dose Proton Therapy Improves Survival of Patients with Icteric Type Hepatocellular Carcinoma (HCC) (2019) (0)
- Thelarge formofhepatitis 6antigen iscrucial forassembly of hepatitis 6virus (1991) (0)
- Noninvasive diagnosis of hepatic fibrosis by biofibroscore® in patients with chronic hepatitis C virus infection (2017) (0)
- Serum Mac-2 Binding Protein Glycosylation Isomer to Predict the Severity of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection (2022) (0)
- Sofosbuvir/velpatasvir or glecaprevir/pibrentasvir for treating patients with hepatitis C virus reinfection following direct‐acting antiviral‐induced sustained virologic response (2021) (0)
- E‐Poster Presentations – B1) Liver (2017) (0)
- Antiviral treatment for hepatitis B in infancy: Still an issue for debate. (2019) (0)
- Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan (2021) (0)
- Reply: To PMID 24002804. (2014) (0)
- Prediction of hepatitis B virus reactivation in lymphoma patients with resolved hepatitis B virus infection who received rituximab-containing chemotherapy: the roles of antiHBc/antiHBs quantification (2017) (0)
- Regulatory T cells alleviate allergic airway hyper‐responsiveness by modulating angiogenesis in airway remodelling (2007) (0)
- Interspousal transmission of TT virus: Low efficiency and lack of apparent risk factors (2000) (0)
- HCV infection in volunteer blood donors in Taiwan: a 6-year follow-up (2002) (0)
- Activation of PI 3 K / Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells (2011) (0)
- O.076 Development of RNA interference-based strategies to control hepatitis B virus clinical isolate of various genotypes and mutants and prevent emergence of resistant mutants (2006) (0)
- 697 AN OPEN-LABEL, COMPARATIVE, MULTICENTRE STUDY OF PEGINTERFERON ALFA-2A (40KD) PLUS RIBAVIRIN IN THE TREATMENT OF PATIENTS CHRONICALLY INFECTED WITH HCV/HBV OR HCV ALONE (2008) (0)
- Reply (2003) (0)
- Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection (2018) (0)
- Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study (2018) (0)
- genotype of donor β synergism between IL-10 genotype of patient and IL-10 receptor graft-versus-host disease following hematopoietic cell transplantation: Genetic variation in the IL-10 pathway modulates severity of acute (2013) (0)
- Hepatocyte Growth Factor Stimulates the Growth and Activates Mitogen-Activated Protein Kinase in Human Hepatoma Cells (1998) (0)
- Dengue virus RNA detection rates in blood donors correlates with local infection incidences during a dengue outbreak in Taiwan. (2022) (0)
- Structure and replication of the genome of the hepatitis 6 virus (viroids/virusoids) (1999) (0)
- Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA‐binding function (2022) (0)
- Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis (2017) (0)
- Hepatitis D double reflex testing of all hepatitis B carriers in low HBV and high HBV/high HDV prevalence countries. (2023) (0)
- Induction of humoral and cellular immune responses to hepatitis delta virus through DNA immunization in BALB/c mice. (2004) (0)
- Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis (2020) (0)
- Sensitization of hepatocellular carcinoma (HCC) to tigatuzumab (CS-1008), a humanized anti-DR5 antibody, by sorafenib and its derivative SC-49. (2012) (0)
- Lamivudine and Hepatitis B Reactivation (2009) (0)
- 1158 Adjuvant methotrexate, vinblastine, and cisplatin chemotherapy for invasive transitional cell carcinoma-Taiwan experience (1995) (0)
This paper list is powered by the following services:
Other Resources About Chen Pei-jer
What Schools Are Affiliated With Chen Pei-jer?
Chen Pei-jer is affiliated with the following schools:
